| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Active immunity is seen as a reduction in the cell response to oral live vaccine
|
Kantele, A.
|
|
1991
|
9 |
6 |
p. 428-431
4 p.
|
article
|
| 2 |
A meeting to find a common strategy to achieve universal immunization of all children
|
Rappuoll, Rino
|
|
1991
|
9 |
6 |
p. 463-
1 p.
|
article
|
| 3 |
Calendar
|
|
|
1991
|
9 |
6 |
p. 464-
1 p.
|
article
|
| 4 |
Delineation of protective epitopes on the E2-envelope glycoprotein of Semliki Forest virus
|
Grosfeld, Haim
|
|
1991
|
9 |
6 |
p. 451-456
6 p.
|
article
|
| 5 |
Different profiles of the human immune response to primary and secondary immunization with an oral Salmonella typhi Ty21a vaccine
|
Kantele, A.
|
|
1991
|
9 |
6 |
p. 423-427
5 p.
|
article
|
| 6 |
Early predictor of the efficacy of immunoprophylaxis against perinatal hepatitis B transmission: analysis of prophylaxis failure
|
Lin, Ho-Hsiung
|
|
1991
|
9 |
6 |
p. 457-460
4 p.
|
article
|
| 7 |
Effective postexposure treatment of rabies-infected sheep with rabies immune globulin and vaccine
|
Blancou, J.
|
|
1991
|
9 |
6 |
p. 432-437
6 p.
|
article
|
| 8 |
Feline T-cell lymphotropic lentivirus proteins; cat FIV virus used for the specific detection of FIV antibodies, production of antibodies and in vaccine; DNA sequence
|
|
|
1991
|
9 |
6 |
p. 462-
1 p.
|
article
|
| 9 |
Hepatitis B virus infection in hospital staff: epidemiology and persistence of vaccine-induced antibodies
|
Dentico, P.
|
|
1991
|
9 |
6 |
p. 438-442
5 p.
|
article
|
| 10 |
Herpes virus recombinant pox virus recombinant vaccine; recombinant vaccinia virus, canary-pox virus, fowl-pox virus construction by insertion of glycoprotein gene from foreign herpes virus, pseudorabies virus, Epstein-Barr virus or cytomegalovirus
|
|
|
1991
|
9 |
6 |
p. 461-
1 p.
|
article
|
| 11 |
High antibody responses in rabbits immunized with influenza virus ISCOMs containing a repeated sequence of the Plasmodium falciparum antigen Pf155/RESA
|
Sjölander, Anders
|
|
1991
|
9 |
6 |
p. 443-450
8 p.
|
article
|
| 12 |
Immuno-parasitological parameters in schistosomiasis — A perspective view of a vaccine-oriented immunochemist
|
Arnon, Ruth
|
|
1991
|
9 |
6 |
p. 379-394
16 p.
|
article
|
| 13 |
Interleukin-1 derived synthetic peptide as an added co-adjuvant in vaccine formulations
|
Manivel, Venkatasamy
|
|
1991
|
9 |
6 |
p. 395-397
3 p.
|
article
|
| 14 |
Live or inactivated canine coronavirus vaccine; new antigen dog coronavirus isolate
|
|
|
1991
|
9 |
6 |
p. 461-
1 p.
|
article
|
| 15 |
Nematode protein complex; Haemonchus contortus immunogen and anthelmintic agent; protein sequence; recombinant vaccine production
|
|
|
1991
|
9 |
6 |
p. 462-
1 p.
|
article
|
| 16 |
OmpB (osmo-regulation) and icsA (cell-to-cell spread) mutants of Shigella flexneri: vaccine candidates and probes to study the pathogenesis of shigellosis
|
Sansonetti, Philippe J.
|
|
1991
|
9 |
6 |
p. 416-422
7 p.
|
article
|
| 17 |
Principles of selective inactivation of viral genome. VI. Inactivation of the infectivity of the influenza virus by the action of β-propiolactone
|
Budowsky, E.I.
|
|
1991
|
9 |
6 |
p. 398-402
5 p.
|
article
|
| 18 |
Production of a vaccine against rotavirus disease; live attenuated strain containing the fourth rotavirus gene associated with attenuation
|
|
|
1991
|
9 |
6 |
p. 461-
1 p.
|
article
|
| 19 |
Revaccination with pneumococcal vaccine of elderly persons 6 years after primary vaccination
|
Mufson, Maurice A.
|
|
1991
|
9 |
6 |
p. 403-407
5 p.
|
article
|
| 20 |
Ringworm vaccine; containing antigen from e.g. Microsporum canis, Microsporum gypsum or Trichophyton mentagrophytes
|
|
|
1991
|
9 |
6 |
p. 461-
1 p.
|
article
|
| 21 |
Synthesis of dimeric Lex or difucosyl Y2 cancer antigen; useful as antitumor vaccine and to subside inflammatory processes of rheumatoid arthritis; preparation using α 1–3-fucosyltransferase
|
|
|
1991
|
9 |
6 |
p. 461-
1 p.
|
article
|
| 22 |
The adjuvanticity of Algammulin, a new vaccine adjuvant
|
Cooper, Peter D.
|
|
1991
|
9 |
6 |
p. 408-415
8 p.
|
article
|
| 23 |
Vaccine for preventing or treating T-cell mediated pathology; comprises an effective amount of a T-lymphocyte receptor and a pharmaceutical medium; application in rheumatoid arthritis, multiple sclerosis therapy, diagnosis, prevention
|
|
|
1991
|
9 |
6 |
p. 462-
1 p.
|
article
|
Journal description